![Ian Walters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Walters
Chief Executive Officer at
SalvaRx Ltd.
Profile
Founder of SalvaRx Group Plc, Ian B. Walters presently is Chief Executive Officer & Director at Portage Biotech, Inc., Chief Executive Officer & Director at iOX Therapeutics Ltd. (a subsidiary of Portage Biotech, Inc.) and Chief Medical Officer & Vice President at Intensity Therapeutics, Inc. Ian B. Walters is also on the board of Enzo Biochem, Inc. and RIFT biotherapeutics, Inc. In his past career he was Chief Executive Officer of SalvaRx Group Plc, SVP-Translational Medicine & Corporate Development at Sorrento Therapeutics, Inc. and Member of Bristol-Myers Squibb Canada Co. He received a doctorate from Albert Einstein College of Medicine, Inc. and an MBA from The Wharton School of the University of Pennsylvania.
Ian Walters active positions
| Companies | Position | Start |
|---|---|---|
iOx Therapeutics Ltd.
 iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Director/Board Member | 01/07/2015 |
Stimunity SAS
 Stimunity SAS BiotechnologyHealth Technology Provides biotechnology services | Chairman | - |
SalvaRx Ltd.
 SalvaRx Ltd. BiotechnologyHealth Technology Develops therapies in immuno-oncology market | Chief Executive Officer | - |
Former positions of Ian Walters
| Companies | Position | End |
|---|---|---|
| ALPHA COMPUTE CORP | Chief Executive Officer | 14/12/2024 |
| INTENSITY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2023 |
| SALVARX GROUP PLC | Founder | 08/01/2019 |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Designs, develops and wholesales pharmaceutical services | Chief Operating Officer | 01/03/2014 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Chief Tech/Sci/R&D Officer | - |
Training of Ian Walters
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Enzo Biochem, Inc.
 Enzo Biochem, Inc. BiotechnologyHealth Technology Provides enabling life science technologies for research, drug discovery, drug development and diagnostic solutions | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
AlphaTON Capital Corp.
 AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
3Legs Resources Plc
 3Legs Resources Plc Financial ConglomeratesFinance Invests in acquired companies within the technology sector | Finance |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Designs, develops and wholesales pharmaceutical services | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SalvaRx Ltd.
SalvaRx Ltd. BiotechnologyHealth Technology Develops therapies in immuno-oncology market | Health Technology |
iOx Therapeutics Ltd.
iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Health Technology |
SalvaRx Group Plc
 SalvaRx Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company that focuses on immune-oncology & invests in novel cancer immune-therapies | Commercial Services |
RIFT biotherapeutics, Inc.
 RIFT biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibodies for use in oncology | Commercial Services |
Stimunity SAS
Stimunity SAS BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
- Stock Market
- Insiders
- Ian Walters
Choose MarketScreener 
